These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23435515)

  • 1. Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight--new perspectives?
    Ditschkowski M; Elmaagacli AH; Koldehoff M; Gromke T; Trenschel R; Beelen DW
    Bone Marrow Transplant; 2013 Sep; 48(9):1224-9. PubMed ID: 23435515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.
    Yoshihara S; Tateishi U; Ando T; Kunitoh H; Suyama H; Onishi Y; Tanosaki R; Mineishi S
    Bone Marrow Transplant; 2005 Jun; 35(12):1195-200. PubMed ID: 15852024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation.
    Forslöw U; Mattsson J; Gustafsson T; Remberger M
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1214-21. PubMed ID: 21193056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children.
    Nishio N; Yagasaki H; Takahashi Y; Muramatsu H; Hama A; Tanaka M; Yoshida N; Watanabe N; Kudo K; Yoshimi A; Kojima S
    Bone Marrow Transplant; 2009 Sep; 44(5):303-8. PubMed ID: 19349954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
    Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation.
    Duque-Afonso J; Ihorst G; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Prasse A; Marks R
    Bone Marrow Transplant; 2013 Aug; 48(8):1098-103. PubMed ID: 23376822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased serum levels of clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation.
    Mattsson J; Remberger M; Andersson O; Sundberg B; Nord M
    Transplantation; 2005 May; 79(10):1411-6. PubMed ID: 15912112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakasone H; Kanda J; Yano S; Atsuta Y; Ago H; Fukuda T; Kakihana K; Adachi T; Yujiri T; Taniguchi S; Taguchi J; Morishima Y; Nagamura T; Sakamaki H; Mori T; Murata M;
    Transpl Int; 2013 Jun; 26(6):631-9. PubMed ID: 23551210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia.
    Santo Tomas LH; Loberiza FR; Klein JP; Layde PM; Lipchik RJ; Rizzo JD; Bredeson CN; Horowitz MM
    Chest; 2005 Jul; 128(1):153-61. PubMed ID: 16002929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplant.
    Diab KJ; Yu Z; Wood KL; Shmalo JA; Sheski FD; Farber MO; Wilkes DS; Nelson RP
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1827-34. PubMed ID: 22766224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation.
    Nakaseko C; Ozawa S; Sakaida E; Sakai M; Kanda Y; Oshima K; Kurokawa M; Takahashi S; Ooi J; Shimizu T; Yokota A; Yoshiba F; Fujimaki K; Kanamori H; Sakai R; Saitoh T; Sakura T; Maruta A; Sakamaki H; Okamoto S
    Int J Hematol; 2011 Mar; 93(3):375-382. PubMed ID: 21424350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiolitis obliterans in patients undergoing allogeneic hematopoietic SCT.
    Vieira AG; Funke VA; Nunes EC; Frare R; Pasquini R
    Bone Marrow Transplant; 2014 Jun; 49(6):812-7. PubMed ID: 24614836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
    Lucid CE; Savani BN; Engelhardt BG; Shah P; Clifton C; Greenhut SL; Vaughan LA; Kassim A; Schuening F; Jagasia M
    Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors.
    Ditschkowski M; Elmaagacli AH; Trenschel R; Peceny R; Koldehoff M; Schulte C; Beelen DW
    Haematologica; 2007 Apr; 92(4):558-61. PubMed ID: 17488669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation.
    Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation.
    Afessa B; Litzow MR; Tefferi A
    Bone Marrow Transplant; 2001 Sep; 28(5):425-34. PubMed ID: 11593314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.
    Uhlving HH; Andersen CB; Christensen IJ; Gormsen M; Pedersen KD; Buchvald F; Heilmann C; Nielsen KG; Mortensen J; Moser C; Sengeløv H; Müller KG
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):531-8. PubMed ID: 25498923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: a 10-year experience of the Okayama BMT Group.
    Fujii N; Nakase K; Asakura S; Matsuo K; Nawa Y; Sunami K; Nishimori H; Matsuoka K; Kondo E; Maeda Y; Shinagawa K; Hara M; Tanimoto M
    Int J Hematol; 2014; 99(5):644-51. PubMed ID: 24634108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.